Relmada Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Relmada Therapeutics Inc
CIK #0001553643, 0001554535
EDGAR Form CIK 2011 - 2026
10-K [0001553643]
10-Q [0001553643]
3 [0001553643]
4 [0001553643]
5 [0001553643]
8-K [0001553643]
D [0001553643]
SC 13D [0001553643]
SC 13G [0001553643]
D [0001554535]
Form 13D/13G Filer Form 13D/13G Subject Filed
Millennium Management LLC Relmada Therapeutics Inc [2026-06-22]
Venrock Healthcare Capital Partners III LP Relmada Therapeutics Inc [2026-06-09]
Commodore Capital LP Relmada Therapeutics Inc [2026-05-04]
Spruce Street Capital LP Relmada Therapeutics Inc [2026-02-17]
Adage Capital Management LP Relmada Therapeutics Inc [2026-02-12]
Janus Henderson Group PLC Relmada Therapeutics Inc [2026-02-06]
Ikarian Capital LLC Relmada Therapeutics Inc [2025-11-14]
Squadron Capital Management LLC Relmada Therapeutics Inc [2025-05-01]
Vanguard Group Inc Relmada Therapeutics Inc [2023-02-09]
Kotler Kevin Relmada Therapeutics Inc [2022-12-20]
View All
Form 3/4/5 Subject 2011 - 2026
Relmada Therapeutics Inc
Casamento Charles J
Traversa Sergio
Shenouda Maged
Ence Chuck
Fedeli Fabiana
Glasspool John
Kelly Paul Edward
Schmidt Eric Thomas
O'Gorman Cedric
Wessel Thomas
Vitolo Ottavio V
Agharkar Shreeram
Nolan Lisa
Seth Sandesh
Salinas Eliseo Oreste
Beck Douglas
Yazgi Nabil
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Relmada Therapeutics Inc RLMD
Common Stock
2025-12-15 Buy 11,665 $4.12 48,060
Relmada Therapeutics Inc RLMD
Common Stock
2025-12-15 Buy 27,500 $4.12 113,300
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 164,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 828,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 164,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 164,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 828,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 1,198,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Appreciation Rights · derivative
2025-12-12 Grant 828,000 $0.00
Relmada Therapeutics Inc RLMD
Common Stock
2025-11-05 Buy 90,000 $2.20 198,000
Relmada Therapeutics Inc RLMD
Common Stock
2025-11-05 Buy 136,000 $2.20 299,200
Relmada Therapeutics Inc RLMD
Common Stock
2025-11-05 Buy 272,500 $2.20 599,500
Relmada Therapeutics Inc RLMD
Common Stock
2025-11-05 Buy 500,000 $2.20 1,100,000
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 400,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 800,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 400,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 100,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 100,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 100,000 $0.00
Relmada Therapeutics Inc RLMD
Stock Option (right to buy) · derivative
2025-06-26 Grant 600,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com